Introduction
Snake envenomation and resultant clinical syndromes fascinate clinicians as they tend to have varied presentations and we do not yet fully understand their pathophysiology. We describe a patient who developed thrombotic microangiopathy (TMA) and isolated fibrinolysis following a hump-nosed viper (Hypnale sp.) bite. Difference between the venom induced consumptive coagulopathy (VICC) and the disseminated intravascular coagulation (DIC) is discussed to understand the resultant coagulopathy from this envenomation.
Case report
A 35-year old man who was bitten on his right leg by 
Thrombotic microangiopathy and fibrinolysis after hump-nosed viper envenomation

Discussion
Hump-nosed viper (genus Hypnale, family Crotalinae) is a moderately venomous snake found in India and Sri Lanka. In a series involving 10 hospitals in Sri Lanka, hump-nosed viper bites accounted for 35% of snake bite admissions [1] . Most victims show local swelling, pain and bleeding. Haemorrhagic blisters are seen at the bite site and rarely have lead to amputations [1] . One series failed to report any systemic toxicity [2] . However, there are several reports of coagulopathy, thrombocytopenia and acute renal failure occurring in isolation and in combination after hump-nosed viper envenomation [3] [4] [5] . In a series of 302 cases of confirmed hump-nosed viper bites, 10% had developed acute renal failure and 39% had incoagulable blood (20mins WBCT) but data on platelet counts were not available [1] .
The combination of acute renal failure, thrombocytopenia and microangiopathic haemolytic anaemia characterises thrombotic microangiopathy and in snake envenoming it usually occurs in association with VICC [6] . In our patient coagulopathy was confined to a raised D Dimer level suggesting hypofibrogenaemia. His WBCT, PT and PTTK remained within normal limits. Coagulopathy in snake envenomation depends on which point the coagulation cascade is activated by the procoagulant snake toxin. This is a major difference in VICC from where coagulation is activated by tissue factor/ factor VII pathway [6] . It is difficult to predict the type of coagulopathy from the envenomation as most snake venom contains a mixture of procoagulant toxins acting at different points of the coagulation cascade. Apart from basic clotting tests, few laboratory data are available on the coagulopathy of snake venom in clinical studies. Out of procoagulant toxins present in viper venom, Thrombin Like Enzyme (TLE) mainly causes hypofibrogenaemia [7] . Often this hypofibrogenaemia is associated with thrombocytopenia [8] . Considering our patient's elevated D dimer (hypofibrogenaemia) and thrombocytopenia it is safe to assume hump-nosed viper venom contains predominantly TLEs as procoagulant toxin.
Unlike in DIC, coagulopathy in VICC has a rapid onset and resolves within 24-48 hours. Despite the resolution of the VICC, thrombotic microangiopathy progresses. This suggests an involvement of a different toxin to procoagulant toxin initiating TMA [6] . In combination with renal failure this clinical picture is similar to haemolyticuremic syndrome which usually results from a toxin causing renal endothelial damage. It is possible that a toxin in venom is causing a similar endothelial damage initiating the thrombotic microangiopathy [9] .
The treatment for hump-nosed envenomation is supportive to date as there is no effective antivenom. Acute renal failure is treated with dialysis and therapeutic transfusions as required. TMA has been treated with plasmapheresis. However, its role remains uncertain [9] . It is important to appreciate that the onset, progression and resolution of VICC differ from that of DIC because it helps to understand the clinical syndromes that result from snake envenomation.
